IRF3 and neoplasm: The pathway exerts context-dependent effects: Antitumor: When the IRF3/IFN-I axis predominates, STING activation in dendritic cells potently primes CD8+ T-cell responses (91), transforming immunologically “cold” tumors into “hot” microenvironments conducive to tumor cell clearance.